🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Fluticasone propionate 250 mcg BID

Found 57 matching trials

A Dose-Finding Study Evaluating Safety and Efficacy in Patients With Chronic Obstructive Pulmonary Disease

PHASE2

The purpose of the study is to determine the appropriate dose of fluticason...

Status

Completed

Location

Research Site

Start Date

2006-11

Trial ID

NCT00403286

Treatments Being Tested

Fluticasone Propionate/Formoterol Fumarate Fluticasone Propionate/Formoterol Fumarate Fluticasone Propionate/Formoterol Fumarate Fluticasone Propionate/Formoterol Fumarate Fluticasone Propionate Formoterol Fumarate Fluticasone Propionate/Salmeterol Xinafoate Placebo

Airway Microbiome in Asthma: Relationships to Asthma Phenotype and Inhaled Corticosteroid Treatment

There are new, very sensitive methods for detecting bacteria. These methods...

Status

Completed

Location

University of California, San Francisco, Adult

Start Date

2012-10

Trial ID

NCT01537133

Treatments Being Tested

fluticasone Placebo

Chronic Obstructive Pulmonary Disease (COPD) Post-hospitalization Study

PHASE4

This trial is a randomized, double-blind, parallel-group, multicenter study...

Status

Completed

Location

GSK Investigational Site

Start Date

2010-04-30

Trial ID

NCT01110200

Treatments Being Tested

ADVAIR DISKUS 250/50 mg BID SEREVENT 50 mcg BID

Study of FlutiForm® Versus Fluticasone Plus Formoterol in Adult Subjects With Severe Asthma

PHASE3

The study compares the efficacy and safety of FlutiForm® vs Flixotide® plus...

Status

Completed

Location

Multiple Locations

Start Date

2008-09

Trial ID

NCT00734318

Treatments Being Tested

Flutiform 250/10 micrograms Flutiform 50/5 micrograms Flixotide pMDI 250 mcg + foradil pMDI 24 micrograms Flixotide pMDI 250 micrograms

Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

PHASE4

The purpose of this study is to evaluate the site and mechanisms responsibl...

Status

Recruiting

Location

Arthur F Gelb Medical Corporation

Start Date

2007-10

Trial ID

NCT01225913

Treatments Being Tested

fluticasone/salmeterol in all asthmatics budesonide/formoterol or fluticasone/salmeterol in all asthmatics

A Phase III Parallel Group Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination (FDC) of Fluticasone Furoate+Umeclidinium Bromide+Vilanterol (FF/UMEC/VI) With the FDC of FF/VI in Subjects With Inadequately Controlled Asthma

PHASE3

A once-daily 'closed' triple FDC therapy of FF/UMEC/VI via a single ELLIPTA...

Status

Completed

Location

GSK Investigational Site

Start Date

2016-10-13

Trial ID

NCT02924688

Treatments Being Tested

FF/UMEC/VI (100/31.25/25) mcg FF/UMEC/VI (100/62.5/25) mcg FF/UMEC/VI (200/31.25/25) mcg FF/UMEC/VI (200/62.5/25) mcg FF/VI (100/25) mcg FF/VI (200/25) mcg Fluticasone/salmeterol (FSC)Albuterol/salbutamol ELLIPTA DPI DISKUS DPI METERED-DOSE INHALER (MDI)

Comparative Study on Usability of Inhaler Devices in Adults With Asthma or COPD

This is a randomized, multi-center, active-controlled, repeated measures de...

Status

Completed

Location

3) Fondazione S. Maugeri - IRCCS - Dipartimento di Pneumologia Riabilitativa

Start Date

2016-04

Trial ID

NCT02757209

Treatments Being Tested

Spiromax (budesonide/formoterol)Turbohaler (budesonide/formoterol)Diskus(50mcg salmeterol &250/500 mcg fluticasone propionate)

A Non-inferiority Study to Evaluate the Efficacy, Safety, and Tolerability of Fluticasone Propionate/Salmeterol (FSC) 250/50 Microgram (mcg) Through a Capsule-Based Inhaler and a Multi-Dose Inhaler Administered Twice Daily (BID) in Adults With Chronic Obstructive Pulmonary Disease (COPD)

PHASE3

This is a multi-centre, randomised, double-blind, double-dummy, two way cro...

Status

Completed

Location

GSK Investigational Site

Start Date

2013-11-14

Trial ID

NCT01978145

Treatments Being Tested

FSC Placebo

Childhood Asthma Research and Education (CARE) Network Trial - Best Add-On Therapy Giving Effective Response (BADGER)

PHASE3

Asthma is a common, serious illness among children in the United States. Wh...

Status

Completed

Location

University of Arizona College of Medicine

Start Date

2007-03

Trial ID

NCT00395304

Treatments Being Tested

fluticasone propionate + montelukast fluticasone propionate fluticasone propionate + salmeterol

Effects of Mometasone Furoate Dry Powder Inhaler, Fluticasone Propionate, and Montelukast on Bone Mineral Density in Asthmatics (Study P03418)

PHASE4

This is a randomized, multi-center, parallel-group, active-controlled, doub...

Status

Completed

Location

Multiple Locations

Start Date

2006-09

Trial ID

NCT00394355

Treatments Being Tested

mometasone furoate dry powder inhaler mometasone furoate dry powder inhaler fluticasone propionate hydrofluoroalkane (HFA)montelukast

Previous Next